Possible mechanisms of improved radiation response by cytotoxic RNase, Onconase, on A549 human lung cancer xenografts of nude mice.

Abstract

The cytotoxic RNase, Onconase (ONC), isolated from amphibian oocytes, was used to study its effect on the radiation response in A549 human NSCLC in vitro and in vivo. In cell culture studies, we found that ONC increased the radiation response by ONC-induced inhibition of O2 consumption (QO2). The occurrence of apoptosis was increased by ONC and was dependent on dosages and time exposure (measured by a Tunnel in situ cell death detection assay). Moreover, ONC inhibited sublethal damage repair (SLDR), confirmed by a split dose experiment. In animal studies, ONC significantly increased the radiation-induced tumor growth delay of A549 tumors in vivo. Using a non-invasive DCE-MRI technology, ONC-induced changes of perfusion were observed in A549 tumors. We concluded that the ONC-induced enhancement in tumor oxygenation was mainly due to the reduction in QO2 rather than an increase in tumor blood flow. This investigation suggests important potential clinical uses of ONC for the treatment of NSCLC cancer patients.

• Authors: Dae Hong Kim, Eun Ju Kim, Anna Kalota, Alan M Gewirtz, Jerry Glickson, Kuslima Shogen, Intae Lee
• Journal: Advances in experimental medicine and biology (Adv Exp Med Biol) Vol. 599 Pg. 53-9 ( 2007) ISSN: 0065-2598 [Print] United States
• PMID: 17727247 (Publication Type: Evaluation Study, Journal Article)

Chemical References

• Antineoplastic Agents
• Ribonucleases
• ranpirnase

Topics

• Animals
• Antineoplastic Agents (pharmacology, therapeutic use)
• Cell Line, Tumor (drug effects, radiation effects)
• Female
• Humans
• Lung Neoplasms (drug therapy, radiotherapy)
• Mice
• Mice, Nude
• Neoplasm Transplantation
• Ribonucleases (pharmacology, therapeutic use)
• Transplantation, Heterologous